4
Changes in Ownership
AbCellera Biologics Inc. Filed Acc 0001628280-25-000233
Options or other derivatives
- Chief Financial Officer acquired 1,352,054 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Booth Andrew Chief Financial Officer | 2025-01-01 | Grant or award · Share option (right to buy) | +1,352,054 | 7,942,951 | D | ||
Loading xslF345X05/wk-form4_1735936673.xml…